Release Date: 28/01/14 13:04 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 212.53KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%